8.21
Katherine Unger Baillie
Science News Officer
kbaillie@upenn.edu
Cancer Research
Balance of ‘stop’ and ‘go’ signaling could be key to cancer immunotherapy
Balance of ‘stop’ and ‘go’ signaling could be key to cancer immunotherapy
A Penn study shows potential of the interferon pathway as a biomarker to help predict which patients are likely to respond to immunotherapies.
A new cancer drug, thanks to a new approach
A new cancer drug, thanks to a new approach
Researchers in the Abramson Cancer Center helped bring new hope to patients with multiple myeloma with a drug that targets the command center of a cancer cell.
Hormone therapy for prostate cancer may raise risk of Alzheimer’s, dementia
Hormone therapy for prostate cancer may raise risk of Alzheimer’s, dementia
A Penn study of more than 150,000 men with prostate cancer shows androgen deprivation therapy was associated with a higher likelihood of developing dementia when compared to patients who were not exposed to the treatment.
Shorter courses of proton therapy can be just as effective on prostate cancer
Shorter courses of proton therapy can be just as effective on prostate cancer
Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments, and is safe for patients.
One simple change can reduce frequent cancer imaging by half
One simple change can reduce frequent cancer imaging by half
A “nudge” is helping shorten treatment time for patients with advanced cancer, with less frequent palliative radiation therapy sessions.
Elderly patients with metastatic renal cell carcinoma benefit from targeted therapies
Elderly patients with metastatic renal cell carcinoma benefit from targeted therapies
A Penn study of Medicare patients who are often underrepresented in medical trials finds overall survival benefits from treatment with targeted therapies.
Chemo is a go for treating equine lymphoma
Chemo is a go for treating equine lymphoma
New Bolton Center’s Daniela Luethy’s research on 15 horses with lymphoma concluded that chemotherapy had encouraging results. Her study poses opportunities for further research with more case control.
How to reinvigorate exhausted immune cells to stop cancer
How to reinvigorate exhausted immune cells to stop cancer
A Penn study has identified a protein called TOX that regulates exhausted T-cells, and could be a key to new immunotherapies.
OncoLink: 25 years—and millions of hits—later
OncoLink: 25 years—and millions of hits—later
The online source for cancer information turns 25. Last year alone, the website had 4.5 million visits, with half from other countries, and nurses looking for reliable material to educate patients.
Better prognosticating for dogs with mammary tumors
Better prognosticating for dogs with mammary tumors
For dogs with mammary tumors, a course of treatment can depend on a variety of factors, some of which may seem to contradict one another. A new system developed by Penn Vet’s Karin Sorenmo and colleagues can make determining a prognosis and making treatment decisions an easier task.
Media Contact
Experts
In the News
HealthDay News
For Breast Cancer Patients, Less Time on Hormonal Meds?
Susan Domchek of the Perelman School of Medicine and the Abramson Cancer Center comments on hormonal therapy.
FULL STORY →
Nature
Acupuncture in Cancer Study Reignites Debate About Controversial Technique
Rollin Gallagher of the Perelman School of Medicine comments on a clinical trial that focused on whether acupuncture can relieve pain in cancer patients.
FULL STORY →